Sensitization of TRPV1 by EP1 and IP Reveals Peripheral Nociceptive Mechanism of Prostaglandins

Overview of attention for article published in Molecular Pain, January 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

patent: 9 patents

Citations

dimensions_citation: 464 Dimensions

Readers on

mendeley: 234 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

INHIBITORS OF GPR132 FOR USE IN PREVENTING AND/OR TREATING CHEMOTHERAPY-INDUCED…

Application WO-2018055082-A1

World Intellectual Property Organisation (WIPO)

EP1 receptor ligands

Application US-9518015-B2

United States of America

SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS

Application WO-2013149997-A1

World Intellectual Property Organisation (WIPO)

SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS

Application WO-2013149996-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 5 additional patents.